Impact in Clinical Practice of the European Medicines Agency Health Alert About the Restriction of the Use of JAK Inhibitors - Castañeda-Estévez, Elisabet; Vergara-Dangond, Cristina; Steiner, Martina; Paredes-Romero, Maria Beatriz; Esteban-Vázquez, Ana; Cobo-Ibañez, Tatiana; Trives-Folguera, Laura; Romero-Bogado, Maria Liz; De La Cámara-Fernández, Isabel; Richi-Alberti, Patricia; Acosta-Alfaro, Ana; De la Osa-Subtil, Iría; et al. (Pharmaceuticals (Basel, Switzerland), 2025)
Keywords: Adverse and side effects; Blood pressure; Brief Report; Cancer therapies; Cardiovascular disease; cardiovascular risk; Clinical medicine; Clinical trials; Cytokines; Diabetes; Drugs; health alert; High density lipoprotein; Hypertension; Ischemia; JAK inhibitors; Kinases; Lupus; Metabolic disorders; Normal distribution; Pathogenesis; Patients; Rheumatoid arthritis; Rheumatology; Statistical analysis; Stroke; Surveillance; TNF inhibitors; Tumor necrosis factor-TNF; Tumors; Spain; health alert; JAK inhibitors; cardiovascular risk